1. Moody TW Mantey SA Pradhan TK Schumann M Nakagawa T Martinez A Fuselier J Coy DH Jensen RT Development of high affinity camptothecin-bombesin conjugates that have targeted cytotoxicity for bombesin receptor-containing tumor cells. J Biol Chem (279): 23580-9, 2004. [Full Text/Abstract]
2. Norton JA Alexander HR Fraker DL Venzon DJ Gibril F Jensen RT Does the use of routine duodenotomy (DUODX) affect rate of cure, development of liver metastases, or survival in patients with Zollinger-Ellison syndrome? Ann Surg (239): 617-25; discussion 626, 2004. [Full Text/Abstract]
3. Gibril F Schumann M Pace A Jensen RT Multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: a prospective study of 107 cases and comparison with 1009 cases from the literature. Medicine (Baltimore) (83): 43-83, 2004. [Full Text/Abstract]
4. Chen YJ Vortmeyer A Zhuang Z Gibril F Jensen RT X-chromosome loss of heterozygosity frequently occurs in gastrinomas and is correlated with aggressive tumor growth. Cancer (100): 1379-87, 2004. [Full Text/Abstract]
5. Tapia JA Garcia-Marin LJ Jensen RT Cholecystokinin-stimulated protein kinase C-delta kinase activation, tyrosine phosphorylation, and translocation are mediated by Src tyrosine kinases in pancreatic acinar cells. J Biol Chem (278): 35220-30, 2003. [Full Text/Abstract]
6. Schumann M Nakagawa T Mantey SA Tokita K Venzon DJ Hocart SJ Benya RV Jensen RT Importance of amino acids of the central portion of the second intracellular loop of the gastrin-releasing Peptide receptor for phospholipase C activation, internalization, and chronic down-regulation. J Pharmacol Exp Ther (307): 597-607, 2003. [Full Text/Abstract]
7. Chen YJ Vortmeyer A Zhuang Z Huang S Jensen RT Loss of heterozygosity of chromosome 1q in gastrinomas: occurrence and prognostic significance. Cancer Res (63): 817-23, 2003. [Full Text/Abstract]
8. Pace A Garcia-Marin LJ Tapia JA Bragado MJ Jensen RT Phosphospecific site tyrosine phosphorylation of p125FAK and proline-rich kinase 2 is differentially regulated by cholecystokinin receptor type A activation in pancreatic acini. J Biol Chem (278): 19008-16, 2003. [Full Text/Abstract]
9. Abou-Saif A Gibril F Ojeaburu JV Bashir S Entsuah LK Asgharian B Jensen RT Prospective study of the ability of serial measurements of serum chromogranin A and gastrin to detect changes in tumor burden in patients with gastrinomas. Cancer (98): 249-61, 2003. [Full Text/Abstract]
10. Peghini PL Annibale B Azzoni C Milione M Corleto VD Gibril F Venzon DJ Delle Fave G Bordi C Jensen RT Effect of chronic hypergastrinemia on human enterochromaffin-like cells: insights from patients with sporadic gastrinomas. Gastroenterology (123): 68-85, 2002. [Full Text/Abstract]
11. Igarashi H Ito T Pradhan TK Mantey SA Hou W Coy DH Jensen RT Elucidation of the vasoactive intestinal peptide pharmacophore for VPAC(2) receptors in human and rat and comparison to the pharmacophore for VPAC(1) receptors. J Pharmacol Exp Ther (303): 445-60, 2002. [Full Text/Abstract]
12. Tokita K Hocart SJ Coy DH Jensen RT Molecular basis of the selectivity of gastrin-releasing peptide receptor for gastrin-releasing peptide. Mol Pharmacol (61): 1435-43, 2002. [Full Text/Abstract]
13. Tokita K Katsuno T Hocart SJ Coy DH Llinares M Martinez J Jensen RT Molecular basis for selectivity of high affinity peptide antagonists for the gastrin-releasing peptide receptor. J Biol Chem (276): 36652-63, 2001. [Full Text/Abstract]
14. Mantey SA Coy DH Pradhan TK Igarashi H Rizo IM Shen L Hou W Hocart SJ Jensen RT Rational design of a peptide agonist that interacts selectively with the orphan receptor, bombesin receptor subtype 3. J Biol Chem (276): 9219-29, 2001. [Full Text/Abstract]
15. Tokita K Hocart SJ Katsuno T Mantey SA Coy DH Jensen RT Tyrosine 220 in the 5th transmembrane domain of the neuromedin B receptor is critical for the high selectivity of the peptoid antagonist PD168368. J Biol Chem (276): 495-504, 2001. [Full Text/Abstract]
16. Benya RV Kusui T Katsuno T Tsuda T Mantey SA Battey JF Jensen RT Glycosylation of the gastrin-releasing peptide receptor and its effect on expression, G protein coupling, and receptor modulatory processes. Mol Pharmacol (58): 1490-501, 2000. [Full Text/Abstract]
17. Roy PK Venzon DJ Shojamanesh H Abou-Saif A Peghini P Doppman JL Gibril F Jensen RT Zollinger-Ellison syndrome. Clinical presentation in 261 patients. Medicine (Baltimore) (79): 379-411, 2000. [Full Text/Abstract]